PAPER
Synthesis of Mono-meso-arylmesoporphyrins III
879
was purified by column chromatography (silica gel, 14 × 2.5 cm,
CH2Cl2–hexane, 2:1) to give 13 (290 mg, 80%) as a clear oil.
1H NMR (300 MHz, CDCl3): d = 0.88 [t, J = 7.5 Hz, 6 H, CH3 (32,
72)], 1.52 [s, 18 H, C[CH3]3], 2.23 [s, 6 H, CH3 (21, 81)], 2.28 [q,
J = 7.5 Hz, 4 H, CH2 (31, 71)], 2.58 [s, 3 H, CH3 (56)], 5.58 [s, 1 H,
CH (5)], 7.18 [d, J = 8.4 Hz, 2 H, CH (52)], 7.88 [d, J = 8.4 Hz, 2 H,
CH (53)], 8.28 [br, 2 H, NH].
1H NMR (300 MHz, CDCl3): d = 0.86 [t, J = 7.6 Hz, 6 H, CH3 (32,
72)], 2.27 [m, 10 H, CH2 (31, 71) CH3 (21, 81)], 3.79 [s, 3 H, CH3
(56)], 5.26 [s, 4 H, CH2 (13, 93)], 5.48 [s, 1 H, CH (5)], 6.84 [d,
J = 8.6 Hz, 2 H, CH (53)], 6.99 [d, J = 8.6 Hz, 2 H, CH (52)], 7.29–
7.38 [m, 10 H, CH (15, 16, 17, 95, 96, 97)], 8.24 [br, 2 H, NH].
MS (EI, 20 eV): m/z (%) = 548 (7) [M]+.
Anal. Calcd for C33H44N2O5: C, 72.23; H, 8.08; N, 5.11. Found: C,
72.25; H, 8.09; N, 5.08.
MS (EI, 20 eV): m/z (%) = 604 (5) [M]+, 91 (100).
Dibenzyl 3,7-Diethyl-2,8-dimethyl-5-(4-methylphenyl)dipyrro-
methane-1,9-dicarboxylate (14)
3,7-Diethyl-5-[4-(2-formyl-1-methoxyvinyl)phenyl)-2,8-di-
methyldipyrromethane-1,9-dicarbaldehyde (22)
Following the typical procedure for 13 using 1211 (240 mg, 0.99
mmol), 4-methylbenzaldehyde (0.12 mL, 119 mg, 0.99 mmol), and
PTSA (95 mg, 0.50 mmol) in CHCl3 (30 mL) at reflux for 1 h. Col-
umn chromatography (silica gel, 14 × 2.5 cm, CH2Cl2–hexane, 3:1)
gave 14 (256 mg, 88%) as a clear oil.
Finely, ground dipyrromethane 18 (100 mg, 0.18 mmol) was added
to a flask containing TFA (1 mL) at 20 °C, and after 15 min of stir-
ring HC(OMe)3 (0.5 mL) was added. After a further period of 10
min, the mixture was poured into a cold mixture of H2O–NH3 (4:1,
25 mL). The resulting mixture was extracted with CH2Cl2 (30 mL),
the organic phase was washed with H2O (20 mL), dried (anhyd
Na2SO4), filtered, and evaporated to dryness at reduced pressure (40
°C). The oil thus obtained was purified by column chromatography
(silica gel, 14 × 2.5 cm, CH2Cl2–MeOH, 97:3). The product was
crystallized (CH2Cl2–hexane) to yield 22 (29.5 mg, 37%) as a
cream-colored solid; mp 205–206 °C (dec).
1H NMR (300 MHz, CDCl3): d = 0.96 [t, J = 7.5 Hz, 6 H, CH3 (32,
72)], 2.30 [s, 6 H, CH3 (21, 81)], 2.40 [q, J = 7.5 Hz, 4 H, CH2 (31,
71)], 3.87 [s, 3 H, OCH3], 5.65 [d, J = 7.7 Hz, 1 H, =CHCHO], 5.69
[s, 1 H, CH (5)], 7.14 [d, J = 8.3 Hz, 2 H, CH (52)], 7.43 [d, J = 8.3
Hz, 2 H, CH (53)], 9.42 [d, J = 7.7 Hz, 1 H, =CHCHO], 9.47 [s, 2
H, CHO (11, 91)], 9.70 [br, 2 H, NH].
1H NMR (300 MHz, CDCl3): d = 0.86 [t, J = 7.6 Hz, 6 H, CH3 (32,
72)], 2.23–2.32 [br, 13 H, CH2 (31, 71), CH3 (21, 81), CH3 (55)], 5.25
[s, 4 H, CH2 (13, 93)], 5.49 [s, 1 H, CH (5)], 6.95 [d, J = 7.9 Hz, 2 H,
CH (53)], 7.10 [d, J = 7.9 Hz, 2 H, CH (52)], 7.26–7.39 [m, 10 H, CH
(15, 16, 17, 95, 96, 97)], 8.26 [br, 2 H, NH].
MS (EI, 20 eV): m/z (%) = 588 (2) [M]+, 318 (5), 91 (100).
Dibenzyl 3,7-Diethyl-2,8-dimethyl-5-[4-(trifluoromethyl)phe-
nyl]dipyrromethane-1,9-dicarboxylate (15)
Following the typical procedure for 13 using 1211 (250 mg, 1.03
mmol), 4-(trifluoromethyl)benzaldehyde (185 mg, 1.04 mmol), and
PTSA (100 mg, 0.53 mmol) in CHCl3 (30 mL) at reflux for 30 min.
Column chromatography (silica gel, 12 × 2 cm, CH2Cl2–hexane,
3:1) gave 15 (284 mg, 85%) as a clear oil.
MS (ES): m/z (%) = 447 (10) [M + H]+, 469 (100) [M + Na]+.
Anal. Calcd for C27H30N2O4: C, 72.62; H, 6.77; N, 6.27. Found: C,
72.58; H, 6.79; N, 6.25.
1H NMR (300 MHz, CDCl3): d = 0.87 [t, J = 7.5 Hz, 6 H, CH3 (32,
72)], 2.28 [br, 10 H, CH2 (31, 71), CH3 (21, 81)], 5.26 [s, 4 H, CH2 (13,
93)], 5.60 [s, 1 H, CH (5)], 7.17–7.25 [m, 2 H, CH (52)], 7.27–7.55
[m, 10 H, CH (15, 16, 17, 95, 96, 97)], 7.56–7.60 [d, J = 8.2 Hz, 2 H,
CH (53)], 8.27 [br, 2 H, NH].
Mesoporphyrin III Dimethyl Esters; General Procedure
The corresponding dipyrromethane dibenzyl ester (0.56 mmol) was
dissolved in EtOH (50 mL), 10% Pd/C (300 mg) was added and the
mixture was hydrogenolyzed for 3 h at 3.45 bar. The mixture was
filtered through Celite (which was previously washed with EtOH).
The filtrate was evaporated to dryness (40 °C) and the dipyr-
romethane-1,9-dicarboxylic acid (0.50 mmol, 90%) (as a pale pink
oil) was used without further purification. This compound was then
dissolved in a mixture of anhyd CH2Cl2 (200 mL) and MeOH (30
mL), and the corresponding dipyrromethane-1,9-dicarbaldehyde
(0.50 mmol) was added followed by PTSA (380 mg, 2 mmol). The
mixture was kept at r.t. for 24 h protected from light and sat.
Zn(OAc)2·2H2O in anhyd MeOH (40 mL) was added. After a period
of 72 h under the same conditions, the mixture was concentrated at
reduced pressure (40 °C), and a soln of 5% H2SO4 in MeOH (100
mL) was then added. After a period of 16 h, the mixture was diluted
with CH2Cl2 (150 mL) and the organic phase was washed with H2O
(50 mL), 5% NaHCO3 (50 mL), and H2O (50 mL). The resulting
soln was dried (anhyd Na2SO4), filtered, and evaporated to dryness
at reduce pressure (40 °C). The dark residue was purified by column
chromatography (silica gel, 12 × 2 cm, CH2Cl2–MeOH, 98:2), elut-
ing the red band. The resulting compound was crystallized
(CH2Cl2–hexane) to give a purple powder.
MS (EI, 20 eV): m/z (%) = 642 (3) [M]+, 91 (100).
Dibenzyl 5-(4-Acetylphenyl)-3,7-diethyl-2,8-dimethyldipyrro-
methane-1,9-dicarboxylate (16)
Following the typical procedure for 13 using 1211 (250 mg, 1.03
mmol), p-acetylbenzaldehyde (157 mg, 1.03 mmol), and PTSA (98
mg, 0.52 mmol) in CHCl3 (30 mL) at reflux for 30 min. Column
chromatography (silica gel, 8 × 2 cm) eluting first with CH2Cl2 gave
the excess aldehyde and then with CH2Cl2–MeOH (99:1) gave 16
(260 mg, 82%) as a clear oil.
1H NMR (300 MHz, CDCl3): d = 0.88 [t, J = 7.4 Hz, 6 H, CH3 (32,
72)], 2.27–2.31 [m, 10 H, CH2 (31, 71) CH3 (21, 81)], 2.56 [s, 3 H,
CH3 (56)], 5.23 [s, 4 H, CH2 (13, 93)], 5.60 [s, 1 H, CH (5)], 7.17 [d,
J = 8.4 Hz, 2 H, CH (52)], 7.31–7.36 [m, 10 H, CH (15, 16, 17, 95, 96,
97)], 7.88 [d, J = 8.4 Hz, 2 H, CH (53)], 8.46 [br, 2 H, NH].
MS (EI, 20 eV): m/z (%) = 616 (5) [M]+, 91 (100).
Di-tert-butyl 5-(4-Acetylphenyl)-3,7-diethyl-2,8-dimethyl-
dipyrromethane-1,9-dicarboxylate (18)
Pyrrole 1111 (280 mg, 1.34 mmol), 4-acetylbenzaldehyde (198 mg,
1.34 mmol), and PTSA (127 mg, 0.67 mmol) in CHCl3 (35 mL)
were stirred at r.t. for 3 h. The mixture was diluted with CH2Cl2 (50
mL) and washed with 5% NaHCO3 (30 mL) and H2O (30 mL). The
soln was dried (anhyd Na2SO4), filtered, and the solvent evaporated
at reduced pressure (40 °C). The crude product was subjected to col-
umn chromatography (silica gel, 4 × 4 cm) eluting first with CH2Cl2
gave the excess aldehyde and then with CH2Cl2–MeOH (99:1) gave
18 as a clear oil, which was crystallized (CH2Cl2–hexane) to give a
white powder; yield: 275 mg (76%); mp 132–133 °C.
Mesoporphyrin III Dimethyl Ester
This porphyrin was synthesized in 1965 by Sklyar, Yu. E. et al.18 by
treatment of dipyrrolic units in AcOH–HCl, followed by oxidation
with chloranil. In our case, following the general procedure using
3,7-diethyl-2,8-dimethyldipyrromethane-1,9-dicarboxylic acid21
(230 mg, 0.72 mmol) and 910 (311 mg, 0.77 mmol), with column
chromatography (silica gel, 8 × 2 cm, CH2Cl2–MeOH, 98:2) fol-
lowed by crystallization (CH2Cl2–hexane) yielded the porphyrin
(67 mg, 16%); mp 289–290 °C.
Synthesis 2008, No. 6, 875–882 © Thieme Stuttgart · New York